Gsk (GLAXF) Current Assets (2009 - 2026)

Gsk's Current Assets history runs 18 years deep, the most recent figure standing at $23.9 billion for Q1 2026.

• In Q1 2026, Current Assets rose 5.12% year-over-year to $23.9 billion; the TTM figure through Mar 2026 stood at $23.9 billion (up 5.12% YoY), while the FY2025 annual figure was $23.1 billion, up 6.26% from the prior year.
• Current Assets was $23.9 billion for Q1 2026 at Gsk, up from $23.3 billion in the prior quarter.
• In the past five years, Current Assets ranged from a high of $68.2 billion in Q2 2022 to a low of $20.5 billion in Q1 2022.
• Historically, Current Assets has averaged $25.9 billion across 5 years, with a median of $23.6 billion in 2025.
• The sharpest annual moves came in 2022 and 2023: Current Assets surged 177.93% in 2022, then tumbled 64.52% in 2023.
• A 5-year view of Current Assets shows it stood at $24.4 billion in 2022, then retreated by 5.01% to $23.1 billion in 2023, then fell by 5.72% to $21.8 billion in 2024, then grew by 6.76% to $23.3 billion in 2025, then increased by 2.81% to $23.9 billion in 2026.
• The last three Current Assets figures came in at $23.9 billion (Q1 2026), $23.3 billion (Q4 2025), and $24.1 billion (Q3 2025), per Business Quant data.